NKG2C+CD57+ natural killer cells with senescent features are induced during cutaneous leishmaniasis and accumulate in patients with lesional healing impairment

Clin Exp Immunol. 2024 Aug 9;217(3):279-290. doi: 10.1093/cei/uxae040.

Abstract

Natural killer (NK) cells include different subsets with diverse effector capacities that are poorly understood in the context of parasitic diseases. Here, we investigated inhibitory and activating receptor expression on NK cells in patients with cutaneous leishmaniasis (CL) and explored their phenotypic and functional heterogeneity based on CD57 and NKG2C expression. The expression of CD57 identified NK cells that accumulated in CL patients and exhibited features of senescence. The CD57+ cells exhibited heightened levels of the activating receptor NKG2C and diminished expression of the inhibitory receptor NKG2A. RNA sequencing analyses based on NKG2C transcriptome have revealed two distinct profiles among CL patients associated with cytotoxic and functional genes. The CD57+NKG2C+ subset accumulated in the blood of patients and presented conspicuous features of senescence, including the expression of markers such as p16, yH2ax, and p38, as well as reduced proliferative capacity. In addition, they positively correlated with the number of days until lesion resolution. This study provides a broad understanding of the NK cell biology during Leishmania infection and reinforces the role of senescent cells in the adverse clinical outcomes of CL.

Keywords: NK cells; cellular senescence; cutaneous leishmaniasis; immunopathology; lesional healing.

MeSH terms

  • Adult
  • CD57 Antigens* / immunology
  • CD57 Antigens* / metabolism
  • Cellular Senescence* / immunology
  • Female
  • Humans
  • Killer Cells, Natural* / immunology
  • Leishmaniasis, Cutaneous* / immunology
  • Male
  • Middle Aged
  • NK Cell Lectin-Like Receptor Subfamily C* / immunology
  • NK Cell Lectin-Like Receptor Subfamily C* / metabolism
  • Young Adult

Substances

  • CD57 Antigens
  • NK Cell Lectin-Like Receptor Subfamily C
  • KLRC2 protein, human